The dream is free, but the hustle is sold separately.
The top 15 global brands ranking in past 18 years - and how it has changed rapidly. #Impermanence
$AMRN FDA Grants Priority Review for Vascepa sNDA Seeking Cardiovascular Risk Reduction Indication. PDUFA 09/28/19
$CLVS Q1 Rubraca global sales $42.6M. ↑ 29% YOY $228.4M in cash, cash equivalents. PDUFA May 15th for Rubraca sNDA